Ping-Ping Jiang

Ping-Ping Jiang is an Associate Professor in the Department of Veterinary and Animal Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences. She holds dual appointments in both Comparative Pediatrics and Nutrition, and Preclinical Disease Biology research groups.

Dr. Jiang earned her PhD in Food and Nutritional Sciences from the University of Hong Kong in 2009. Her educational background forms the foundation of her expertise in nutritional science and its applications to vulnerable populations.

Her primary research focuses on the interplay of nutrition, the gut microbiome, and host metabolism in preterm infants' early development and disease. She employs multi-omics analyses, epidemiology, and machine learning techniques to analyze data from human cohorts, clinical trials, and animal models. Her work demonstrates particular emphasis on gut microbiome development, nutritional interventions (especially bovine colostrum), and metabolomics in preterm infants.

Dr. Jiang has published 55 research outputs including journal articles, reviews, and conference abstracts. Analysis of her recent publications (2022-2025) reveals a consistent research trajectory examining how nutritional interventions impact gut microbiome composition and metabolic outcomes in preterm infants. Her work frequently employs piglet models as translational systems for human infant conditions.

• Major research themes include: gut microbiome development in preterm infants, nutritional interventions using bovine colostrum, metabolomics analysis of nutritional effects, and clinical outcomes of nutritional strategies.
• Her interdisciplinary approach bridges veterinary science, pediatrics, and nutritional science, creating valuable translational research that informs both animal and human health practices.

Dr. Jiang maintains an active research profile with multiple publications in high-impact journals including Clinical Nutrition, American Journal of Clinical Nutrition, and Pediatric Research. Her involvement in the PreColos randomized controlled trial demonstrates her commitment to evidence-based nutritional interventions for vulnerable preterm infants.